Preventing a chronic disease like type 2 diabetes saves hundreds of thousands of dollars per patient. However, due to high customer churn and standard one-year contracts, insurance companies see no long-term financial upside in prevention, as another company will likely benefit from their investment.

Employers contribute to soaring health costs not through ill will, but by an unwillingness to challenge the status quo. It is easier to accept industry-wide rate hikes than to ask uncomfortable questions, scrutinize data, or sever long-term relationships with brokers and insurers, thus perpetuating the high-cost cycle.

Care.com's CEO found that selling care benefits to enterprises takes longer than expected—often 18-24 months. This is because rising healthcare costs consume HR budgets, pushing care, considered a "one B benefit," to subsequent budget years and elongating the sales cycle.

The convoluted nature of the health insurance system is not an accident; it is a strategic asset for incumbents. The resulting confusion causes exasperation among employers and consumers, preventing them from effectively questioning costs or believing they can enact change, thereby protecting the industry's profitable, high-cost model.

In a dynamic market, an annual pricing review is too slow and leaves money on the table. A product-led pricing committee should convene quarterly to evaluate market conditions, competitor moves, and customer value perception, enabling more agile adjustments.

The core driver of high insurance costs is the unregulated and widely variable prices charged for identical products and services. Different insurers pay vastly different amounts for the same thing, a market failure hidden from consumers by fixed co-pays, which ultimately leads to ever-increasing premiums for employers.

Health plans have short-term incentives misaligned with long-term chronic care savings. Employers, who bear the costs longest, are the true economic buyers. By acquiring a broker and sharing in cost savings, a startup can align incentives and scale effectively.

Offering discounts early in the quarter doesn't accelerate deals. It signals that better terms will be available later, incentivizing buyers to delay until the last possible minute to maximize their leverage, thus slowing the sales cycle.

Instead of rushing before a deadline, risk advisor Steve Munn approaches prospects after their renewal. This counter-intuitive timing removes the pressure of a decision date, allowing him to conduct a thorough discovery process and position himself as a strategic advisor, not just a vendor competing on price.